The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 346:731-737 March 7, 2002 Number 10
NextNext

Low and Very Low Birth Weight in Infants Conceived with Use of Assisted Reproductive Technology
Laura A. Schieve, Ph.D., Susan F. Meikle, M.D., Cynthia Ferre, M.S., Herbert B. Peterson, M.D., Gary Jeng, Ph.D., and Lynne S. Wilcox, M.D.

 

This Article
-Abstract
- PDF
-PDA Full Text
-PowerPoint Slide Set

Commentary
-Editorial
 by Mitchell, A. A.
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background The increased risk of low birth weight associated with the use of assisted reproductive technology has been attributed largely to the higher rate of multiple gestations associated with such technology. It is uncertain, however, whether singleton infants conceived with the use of assisted reproductive technology may also have a higher risk of low birth weight than those who are conceived spontaneously.

Methods We used population-based data to compare the rates of low birth weight (<=2500 g) and very low birth weight (<1500 g) among infants conceived with assisted reproductive technology with the rates in the general population.

Results We studied 42,463 infants who were born in 1996 and 1997 and conceived with assisted reproductive technology and used as a comparison group 3,389,098 infants born in the United States in 1997. Among singleton infants born at 37 weeks of gestation or later, those conceived with assisted reproductive technology had a risk of low birth weight that was 2.6 times that in the general population (95 percent confidence interval, 2.4 to 2.7). The use of assisted reproductive technology was associated with an increased rate of multiple gestations; however, its use was not associated with a further increase in the risk of low birth weight in multiple births. Among twins, the ratio of the rate of low birth weight after the use of assisted reproductive technology to the rate in the general population was 1.0 (95 percent confidence interval, 1.0 to 1.1). Infants conceived with assisted reproductive technology accounted for 0.6 percent of all infants born to mothers who were 20 years of age or older in 1997, but for 3.5 percent of low-birth-weight and 4.3 percent of very-low-birth-weight infants.

Conclusions The use of assisted reproductive technology accounts for a disproportionate number of low-birth-weight and very-low-birth-weight infants in the United States, in part because of absolute increases in multiple gestations and in part because of higher rates of low birth weight among singleton infants conceived with this technology.


Infants who have low birth weight, either because of early delivery or because of fetal growth restriction, are at increased risk for short- and long-term disabilities and death.1,2 The use of assisted reproductive technology is an important contributor to the rate of low birth weight in the United States because it is associated with a higher rate of multiple birth,3,4 which, in turn, is associated with low birth weight.5 By 1997, the use of assisted reproductive technology accounted for more than 40 percent of triplets born in the United States.4 In addition, studies have suggested that there is a higher rate of low birth weight among singleton infants conceived with assisted reproductive technology than among naturally conceived singleton infants6,7,8 or among all infants in the general population.9,10,11,12,13 However, these studies had methodologic limitations. In particular, they did not address the issue of whether infants born as singletons were conceived as part of a multiple gestation that was later reduced either medically or spontaneously to a singleton pregnancy.

In addition, it remains unclear whether the risk of low birth weight among singleton infants conceived with assisted reproductive technology is a direct effect of the procedure involving such technology14,15 or reflects some other factor related to the underlying infertility of the couples who conceive using these procedures.16,17,18 Studies have been limited by small sample sizes and lack of data regarding such potentially confounding variables as the factors causing infertility and their severity.

We used population-based data from records of procedures performed with assisted reproductive technology in the United States to compare the risk of low birth weight among infants conceived with assisted reproductive technology with that found in the general population. The large sample and detailed data on the procedures and resulting pregnancies provided an opportunity to analyze outcomes according to several important factors, including the number of infants born, the number of fetuses early in the pregnancy, cause of infertility, and factors involved in treatment.

Methods

Study Population

Clinics and medical practices in the United States are required to report data on every procedure involving assisted reproductive technology to the Centers for Disease Control and Prevention (CDC).19 Each year, the Society for Assisted Reproductive Technology collects data on such procedures performed in clinics in the United States and provides these data to the CDC. Procedures involving assisted reproductive technology are defined as procedures for the treatment of infertility in which both oocytes and sperm are handled outside the body; these include in vitro fertilization with transcervical embryo transfer, gamete and zygote intrafallopian transfer (in which gametes or zygotes are transferred into the fallopian tube rather than the uterus), frozen-embryo transfer, and donor-embryo transfer. Data abstracted from patients' records and submitted to the CDC include each patient's demographic characteristics and medical history, as well as clinical information on the procedures performed and resultant pregnancies and births. In 1996, 300 clinics reported more than 60,000 procedures; in 1997, 335 clinics reported more than 70,000 procedures. Five to 7 percent of clinics that were in operation during these years did not report data, despite the federal requirement; because most of these were known to be small practices, we estimate that the data reported represent more than 95 percent of all procedures performed with the use of assisted reproductive technology.

We included in the present analysis infants conceived through procedures performed in 1996 and 1997 in which the mother was between 20 and 60 years of age. Of 136,972 procedures, 23 percent (31,767) resulted in the delivery of one or more liveborn infants. Because some of these were multiple-birth deliveries, the total number of infants was 45,886. Although a delivery could include both liveborn and stillborn infants, we excluded from our analysis the 182 stillborn infants. A total of 3241 infants with missing data on birth weight were also excluded. Our final sample included 42,463 infants conceived with assisted reproductive technology.

Internal Comparisons

We classified infants according to the number at birth (singleton, twin, triplet, or quadruplet or higher-order birth). Although only liveborn infants were included in this study, the assignment of the number born was based on the total number of liveborn and stillborn infants delivered. Within each birth-number group we examined the risk of low and very low birth weight. Birth weight was recorded as a categorical variable in 500-g strata. We defined low birth weight as 2500 g or less and very low birth weight as less than 1500 g.

We assessed variations in risk according to maternal and treatment-related factors, using stratification and multivariable logistic regression. The factors we evaluated included the number of fetal hearts observed on early ultrasonography (i.e., the number of fetuses in the pregnancy), maternal age, parity, primary cause of infertility, previous procedures involving assisted reproductive technology, and the type of procedure that resulted in the current conception. Procedures were classified according to whether the embryos had been fertilized during the current procedure (i.e., were fresh) or had been previously fertilized and frozen until the current procedure and whether the source of the oocytes was the mother herself (nondonor) or another woman serving as an oocyte or embryo donor. In addition, procedures in which a woman other than the mother served as a gestational carrier or surrogate were classified separately. Thus, the procedure was categorized as involving fresh embryos and nondonor oocytes, frozen embryos and nondonor oocytes, fresh embryos and donor oocytes, frozen embryos and donor oocytes, or a gestational carrier. We considered separately whether intracytoplasmic sperm injection (a procedure in which a single sperm is injected directly into the oocyte) was used in procedures involving fresh embryos and nondonor oocytes and those involving fresh embryos and donor oocytes.

External Comparison

We compared the observed numbers of low-birth-weight and very-low-birth-weight infants conceived with assisted reproductive technology with expected numbers. Expected numbers were calculated with the use of the public-use computer file containing the 1997 birth-certificate data for the United States (on 3,389,098 infants born to women who were 20 years of age or older)20 and were adjusted to match the age and parity distributions for women who conceived with assisted reproductive technology. We computed standardized ratios for low birth weight and very low birth weight by dividing the observed numbers by the expected numbers and calculated 95 percent confidence intervals for each estimate.21

To rule out the possibility that the reduction of gestations that had initially involved multiple fetuses might explain a higher rate of low birth weight in singletons, we performed secondary analyses that included only those births in which the number of fetal hearts noted on ultrasonography did not exceed the number of infants who were born. (Data were not available to permit the differentiation of spontaneous reductions from medically induced reductions.) To separate the effects of treatment from underlying characteristics of the patients or embryos, we performed several additional analyses in this subsample. In one analysis, we restricted the sample to infants conceived with the use of donor oocytes among couples without a diagnosis of male-factor infertility, since these infants were considered most likely to have been conceived with healthy gametes. In a second analysis, we restricted the sample to infants born to couples with a diagnosis of male-factor infertility, since women in this subgroup were considered unlikely to have uterine or other infertility-related disease. And in a third analysis, we restricted the sample to infants who had been carried by a gestational surrogate, since these surrogates were presumably healthy women.

Analyses were conducted separately for singletons and twins. In addition, we subdivided low-birth-weight infants into term and preterm infants. Preterm delivery was defined as delivery at less than 37 completed weeks of gestation. We calculated gestational age as the interval from the date of oocyte retrieval and fertilization to the date of birth. For procedures performed with the use of frozen embryos and for other procedures for which the date of oocyte retrieval was missing, the gestational age was calculated as the interval from the date of embryo transfer to the date of birth. To make the estimates comparable with those in the general population, we computed the estimated postmenstrual age (the age according to the last menstrual period) as the gestational age in days plus 14. Term low birth weight was defined as a weight of 2500 g or less with delivery at term; preterm low birth weight was defined as a weight of 2500 g or less with preterm delivery.

To assess the contribution of the use of assisted reproductive technology to low birth weight in the United States, we examined 20,369 infants from our study population who were born in 1997; some had been conceived with assisted reproductive technology in 1996 and some in 1997. For singleton infants, twins, and infants from higher-order multiple births, we divided the number of low-birth-weight and very-low-birth-weight infants conceived with assisted reproductive technology by the total number of low-birth-weight and very-low-birth-weight infants born to women 20 years of age or older in the United States in 1997.

This study was approved by the institutional review board of the CDC; in accordance with federal regulations, the requirement to obtain informed consent was waived for this retrospective analysis.

Results

The study population was similar to the total population of women treated with assisted reproductive technology in terms of the characteristics of the women and the infertility treatment they received (Table 1). However, some factors associated with higher success rates for assisted reproductive technology — an age of less than 35 years, previous deliveries, no previous procedures involving assisted reproductive technology, and the use of fresh embryos (particularly fresh donor embryos) — were slightly more common among the study population.

View this table:
[in this window]
[in a new window]
 
Table 1. Maternal Characteristics and Characteristics of Assisted Reproductive Technology Used.

 
A total of 43 percent of the infants in the study population were singletons, 43 percent were twins, 12 percent were triplets, and 1 percent were quadruplets or higher-order multiples. The percentage of infants with low birth weight varied from 13.2 percent among singletons to almost 100 percent among quadruplets or higher-order multiples. The percentage of infants with low birth weight varied with maternal characteristics and treatment-related factors (Table 2). Singletons were more likely to have low birth weight if there had been more than one fetal heart on early ultrasonography, and twins were more likely to have low birth weight if there had been more than two fetal hearts.

View this table:
[in this window]
[in a new window]
 
Table 2. Percentage of Infants with Low Birth Weight (<=2500 g) among Singletons, Twins, and Triplets Conceived with Assisted Reproductive Technology in 1996 and 1997.

 
The rate of low birth weight was also higher among singletons and twins born to nulliparous women and women who had no previous procedures involving assisted reproductive technology (Table 2). Low birth weight was less common in infants conceived by couples with male-factor infertility, conceived with intracytoplasmic sperm injection, or carried by a gestational surrogate. Among triplets, 90 percent or more of the infants had low birth weight, regardless of maternal characteristics or treatment-related factors. The percentages of quadruplets and higher-order multiples with low birth weight are not shown in Table 2 but were nearly 100 percent in all groups. The results for singletons and twins were materially unchanged after multivariable adjustment for the maternal characteristics and treatment factors listed in Table 2.

The rate of very low birth weight ranged from 2.6 percent for singletons to 66.9 percent for quadruplets or higher-order multiples. The rate of very low birth weight also varied with maternal and treatment-related factors, but to a lesser degree than the rate of low birth weight did (data not shown).

As compared with all singleton infants born in the United States to women 20 years of age or older in 1997, singletons conceived with assisted reproductive technology in 1996 or 1997 were at increased risk for low and very low birth weight (Table 3). When the analysis was restricted to infants who were carried by a gestational surrogate the risk was no longer significantly increased, but there were relatively few infants in this group.

View this table:
[in this window]
[in a new window]
 
Table 3. Observed and Expected Cases of Low Birth Weight and Very Low Birth Weight among Singleton Infants Conceived with Assisted Reproductive Technology in 1996 and 1997.

 
We stratified low-birth-weight infants according to whether they were born at term or were preterm (Table 4). Singleton infants conceived with assisted reproductive technology had a risk of term low birth weight that was more than twice that of singleton infants in the general population, and they had a smaller but still significant increase in the risk of preterm low birth weight. The risk of term low birth weight remained elevated in analyses restricted to subgroups of the study population conceived with presumably healthy gametes or carried by a presumably healthy woman. The risk of preterm low birth weight was no longer increased in analyses restricted to study infants who had been carried by presumably healthy women.

View this table:
[in this window]
[in a new window]
 
Table 4. Observed and Expected Cases of Low Birth Weight among Term and Preterm Singleton Infants Conceived with Assisted Reproductive Technology in 1996 and 1997.

 
Singletons conceived with assisted reproductive technology and delivered at term tended to be born slightly earlier than singletons in the general population (mean gestational age, 39.1 vs. 39.5 weeks). We therefore further adjusted our analyses for the week of gestation at delivery (37 to 41 or more) in addition to maternal age and parity. This adjustment did not substantially change our findings (adjusted term-low-birth-weight ratio, 2.4; 95 percent confidence interval, 2.3 to 2.6).

Among twins conceived with assisted reproductive technology, the risks of both term and preterm low birth weight were similar to those in the general population of twins. The ratio of the rate of low birth weight at term among twins conceived with assisted reproductive technology to the rate among all twins born at term was 1.0 (95 percent confidence interval, 1.0 to 1.1).

The 20,369 infants conceived with assisted reproductive technology and born in 1997 represented 0.6 percent of the 3,389,098 infants born to women 20 years of age or older in the United States in that year. However, we estimate that the use of assisted reproductive technology accounted for 3.5 percent of the infants with low birth weight and 4.3 percent of the infants with very low birth weight born to women in this age group. The excesses were due in large part to the increased number of infants from multiple births who were conceived with assisted reproductive technology. However, the increased rates of low birth weight among singletons conceived with assisted reproductive technology also played a small part (0.6 percent of low-birth-weight singletons were conceived with assisted reproductive technology, as compared with the 0.2 percent that would have been expected).

Discussion

Singleton infants conceived with assisted reproductive technology were at increased risk for low birth weight at term relative to singletons in the general population of the United States. This risk was not explained by known differences between the two populations in the distribution of maternal age, maternal parity, or gestational age at delivery. In addition, there was an increased risk even in analyses in which the sample was restricted to infants from pregnancies that had not originated as multiple gestations, infants conceived with gametes from apparently fertile persons, and infants from pregnancies carried by women who were unlikely to have an underlying uterine or other infertility-related disease. Thus, this study suggests that the increased risk of low birth weight in singleton infants born at term who were conceived with assisted reproductive technology may be directly related to such treatments for infertility.

Singletons who were conceived with assisted reproductive technology also had a moderately elevated rate of preterm low birth weight. However, increased risks were not observed among all subgroups; in particular, the risk was not increased among infants delivered by a gestational carrier rather than the mother. These subgroup analyses involved greatly reduced samples and must therefore be interpreted cautiously. However, a possible explanation is that the risk of preterm low birth weight associated with assisted reproductive technology may be related to some underlying condition in the women who undergo procedures involving such technology rather than to the procedures themselves.

The mechanisms underlying the association between the use of assisted reproductive technology and low birth weight among infants born at term remain unclear and warrant further research. The use of human menopausal gonadotropin as part of procedures involving assisted reproductive technology has been associated with increases in insulin-like growth factor–binding protein 1; this protein has been linked to intrauterine growth restriction.22 During pregnancies initiated with assisted reproductive technology, altered levels of other endometrial proteins and increased rates of structural abnormalities of the placenta have also been found.23,24 These factors may also contribute to growth restriction. A less direct mechanism is also possible. The use of assisted reproductive technology has been linked to such maternal complications as pregnancy-induced hypertension.25,26,27

Studies also suggest that women who have conceived with assisted reproductive technology are more likely to undergo elective cesarean section, resulting in deliveries that occur earlier than those following spontaneous pregnancies.6,7,25,26,27 We did not have data on complications of pregnancy or type of delivery, but we did find that singletons conceived with assisted reproductive technology and born at term were delivered slightly earlier than term singletons in the general population. Adjustment for the week of gestation at delivery did not substantially reduce the risk ratio for low birth weight at term. We observed an excess risk of low birth weight among the singletons conceived with assisted reproductive technology who were born at every week of gestation between 37 and 41 weeks.

Twins conceived with assisted reproductive technology and born at term were not at higher risk of low birth weight than twins in the general population. It is possible that the additional risk associated with the use of assisted reproductive technology is negligible in twin pregnancies, which are already at high risk. Twins conceived with the use of medications for ovarian stimulation but without assisted reproductive technology may also be at increased risk for low birth weight and may have accounted for a sizable proportion of twins in the general population. We do not have data on the use of these medications among the mothers of the general birth cohort.

We did not compare the birth weights of triplets and higher-order multiples in our study population with those in the general population. More than 40 percent of the triplets and higher-order multiples in the general population were conceived with assisted reproductive technology, and the risk of low birth weight was greater than 90 percent among such infants in both groups.

We estimate that more than 3 percent of the low-birth-weight infants and more than 4 percent of the very-low-birth-weight infants born in 1997 were conceived with assisted reproductive technology — six times the proportions that would be expected on the basis of the frequency of these procedures. These higher-than-expected proportions are largely explained by the increased rate of multiple births. Although the use of assisted reproductive technology did not appear to increase the already high risk of low birth weight among infants from multiple gestations, the increased risk of low birth weight among singletons conceived with assisted reproductive technology and delivered at term indicates that infants from both singleton and multiple births must be considered in assessing the effect of assisted reproductive technology on the rate of low birth weight in the United States.

We are indebted to the Society for Assisted Reproductive Technology (SART) for the use of its data-reporting system; and to SART, the American Society for Reproductive Medicine, and Resolve, the National Infertility Association, for their support.


Source Information

From the Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta.

Address reprint requests to Dr. Schieve at the Division of Reproductive Health, Centers for Disease Control and Prevention, Mailstop K-34, 4770 Buford Hwy., NE, Atlanta, GA 30341, or at LJS9{at}cdc.gov.

References

  1. Guyer B, Hoyert DL, Martin JA, Ventura SJ, MacDorman MF, Strobino DM. Annual summary of vital statistics -- 1998. Pediatrics 1999;104:1229-1246. [Free Full Text]
  2. Alberman E. Low birthweight and prematurity. In: Pless IB, ed. The epidemiology of childhood disorders. New York: Oxford University Press, 1994:49-65.
  3. Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology, RESOLVE. 1998 Assisted reproductive technology success rates: national summary and fertility clinic reports, Atlanta: Centers for Disease Control and Prevention, 2000.
  4. Contribution of assisted reproductive technology and ovulation-inducing drugs to triplet and higher-order multiple births -- United States, 1980-1997. MMWR Morb Mortal Wkly Rep 2000;49:535-538. [Medline]
  5. Martin JA, Park MM. Trends in twin and triplet births: 1980–97. National vital statistics reports. Vol. 47. No. 24. Hyattsville, Md.: National Center for Health Statistics, 1999.
  6. Westergaard HB, Johansen AM, Erb K, Andersen AN. Danish National In-Vitro Fertilization Registry 1994 and 1995: a controlled study of births, malformations and cytogenetic findings. Hum Reprod 1999;14:1896-1902. [Free Full Text]
  7. Dhont M, De Sutter P, Ruyssinck G, Martens G, Bekaert A. Perinatal outcome of pregnancies after assisted reproduction: a case-control study. Am J Obstet Gynecol 1999;181:688-695. [CrossRef][Web of Science][Medline]
  8. Verlaenen H, Cammu H, Derde MP, Amy JJ. Singleton pregnancy after in vitro fertilization: expectations and outcome. Obstet Gynecol 1995;86:906-910. [CrossRef][Web of Science][Medline]
  9. Bergh T, Ericson A, Hillensjo T, Nygren KG, Wennerholm UB. Deliveries and children born after in-vitro fertilisation in Sweden 1982-95: a retrospective cohort study. Lancet 1999;354:1579-1585. [CrossRef][Web of Science][Medline]
  10. FIVNAT (French In Vitro National). Pregnancies and births resulting from in vitro fertilization: French National Registry, analysis of data 1986 to 1990. Fertil Steril 1995;64:746-756. [Web of Science][Medline]
  11. Gissler M, Silverio MM, Hemminki E. In-vitro fertilization pregnancies and perinatal health in Finland 1991-1993. Hum Reprod 1995;10:1856-1861. [Free Full Text]
  12. Friedler S, Mashiach S, Laufer N. Births in Israel resulting from in-vitro fertilization/embryo transfer, 1982-1989: National Registry of the Israeli Association for Fertility Research. Hum Reprod 1992;7:1159-1163. [Free Full Text]
  13. MRC Working Party on Children Conceived by In Vitro Fertilisation. Births in Great Britain resulting from assisted conception, 1978-87. BMJ 1990;300:1229-1233.
  14. Sundstrom I, Ildgruben A, Hogberg U. Treatment-related and treatment-independent deliveries among infertile couples, a long-term follow-up. Acta Obstet Gynecol Scand 1997;76:238-243. [Web of Science][Medline]
  15. Olivennes F, Rufat P, Andre B, Pourade A, Quiros MC, Frydman R. The increased risk of complication observed in singleton pregnancies resulting from in-vitro fertilization (IVF) does not seem to be related to the IVF method itself. Hum Reprod 1993;8:1297-1300. [Free Full Text]
  16. Henriksen TB, Baird DD, Olsen J, Hedegaard M, Secher NJ, Wilcox AJ. Time to pregnancy and preterm delivery. Obstet Gynecol 1997;89:594-599. [CrossRef][Web of Science][Medline]
  17. Williams MA, Goldman MB, Mittendorf R, Monson RR. Subfertility and the risk of low birth weight. Fertil Steril 1991;56:668-671. [Web of Science][Medline]
  18. McElrath TF, Wise PH. Fertility therapy and the risk of very low birth weight. Obstet Gynecol 1997;90:600-605. [CrossRef][Web of Science][Medline]
  19. Fertility Clinic Success Rate and Certification Act of 1992 (FCSRCA), Pub. L. No. 102-493 (October 24, 1992).
  20. Natality public use tape. Hyattsville, Md.: National Center for Health Statistics, 1997 (data file).
  21. Clayton D, Hills M. Statistical models in epidemiology. Oxford, England: Oxford University Press, 1993.
  22. Johnson MR, Irvine R, Hills F, et al. Superovulation, IGFBP-1 and birth weight. Eur J Obstet Gynecol Reprod Biol 1995;59:193-195. [CrossRef][Web of Science][Medline]
  23. Johnson MR, Abbas A, Norman-Taylor JQ, et al. Circulating placental protein 14: in the first trimester of spontaneous and IVF pregnancies. Hum Reprod 1993;8:323-326. [Free Full Text]
  24. Jauniaux E, Englert Y, Vanesse M, Hiden M, Wilkin P. Pathologic features of placentas from singleton pregnancies obtained by in vitro fertilization and embryo transfer. Obstet Gynecol 1990;76:61-64. [Web of Science][Medline]
  25. Daniel Y, Ochshorn Y, Fait G, Geva E, Bar-Am A, Lessing JB. Analysis of 104 twin pregnancies conceived with assisted reproductive technologies and 193 spontaneously conceived twin pregnancies. Fertil Steril 2000;74:683-689. [CrossRef][Web of Science][Medline]
  26. Maman E, Lunenfeld E, Levy A, Vardi H, Potashnik G. Obstetric outcome of singleton pregnancies conceived by in vitro fertilization and ovulation induction compared with those conceived spontaneously. Fertil Steril 1998;70:240-245. [CrossRef][Web of Science][Medline]
  27. Tanbo T, Dale PO, Lunde O, Moe N, Abyholm T. Obstetric outcome in singleton pregnancies after assisted reproduction. Obstet Gynecol 1995;86:188-192. [CrossRef][Web of Science][Medline]

 

This Article
-Abstract
- PDF
-PDA Full Text
-PowerPoint Slide Set

Commentary
-Editorial
 by Mitchell, A. A.
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation

Related Letters:

Low and Very Low Birth Weight after Use of Assisted Reproductive Technology
Kovalevsky G., Coutifaris C., Davies M. J., Schieve L. A., Meikle S. F., Ferre C.
Extract | Full Text | PDF  
N Engl J Med 2002; 347:1451-1452, Oct 31, 2002. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.